v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income:        
Revenue
Expenses:        
Research and development 37,197 25,623 117,187 77,740
General and administrative 316,376 868,556 780,491 1,211,810
Interest 80,531 41,209 357,615 230,011
Total expenses 434,104 935,388 1,255,293 1,519,561
Other income 1,250
Net loss $ (434,104) $ (935,388) $ (1,254,043) $ (1,519,561)
Loss per share:        
Basic and diluted (in dollars per share) $ (0.002) $ (0.013) $ (0.006) $ (0.022)
Weighted average shares outstanding, basic and diluted (in shares) 203,710,642 70,103,698 200,016,816 69,358,355

Source